| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM6 GABRG1 CACNA1D CNNM2 ABCA4 SLC22A23 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 SLC7A2 CATSPER1 NALCN CD36 KCNJ12 SCN4A CACNA1I ABCG2 KCNJ18 DISP1 | 1.88e-06 | 1180 | 111 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B SLC9C2 SLC38A1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 1.89e-06 | 465 | 111 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM6 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 3.35e-06 | 343 | 111 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.66e-06 | 123 | 111 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 GABRG1 CACNA1D CNNM2 ABCA4 SLC22A23 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 SLC7A2 CATSPER1 NALCN CD36 KCNJ12 SCN4A CACNA1I ABCG2 KCNJ18 DISP1 | 7.47e-06 | 1289 | 111 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 9.50e-06 | 459 | 111 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 9.97e-06 | 627 | 111 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 1.89e-05 | 664 | 111 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM6 GABRG1 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 1.96e-05 | 758 | 111 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 3.06e-05 | 2 | 111 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 3.06e-05 | 2 | 111 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | lipid binding | ABCA4 ACADM AXL CYP11B1 CYP11B2 ACOX1 RUBCNL PPARA PTAFR PTEN FZD7 CD36 UGT2B7 ZFYVE26 CYP4F12 SEPTIN12 RASAL1 | 3.14e-05 | 988 | 111 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM6 GABRG1 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 3.30e-05 | 793 | 111 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | TRPM6 GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 3.58e-05 | 525 | 111 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM6 GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 3.64e-05 | 526 | 111 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.43e-05 | 115 | 111 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 4.59e-05 | 13 | 111 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.12e-05 | 182 | 111 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.63e-05 | 184 | 111 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.41e-05 | 129 | 111 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 KCNJ12 CACNA1I KCNJ18 | 1.04e-04 | 334 | 111 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.28e-04 | 18 | 111 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.99e-04 | 52 | 111 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.00e-04 | 151 | 111 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.07e-04 | 152 | 111 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | heme binding | 2.22e-04 | 154 | 111 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 3.11e-04 | 164 | 111 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.32e-04 | 166 | 111 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.81e-04 | 239 | 111 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.89e-04 | 171 | 111 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.96e-04 | 26 | 111 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.95e-04 | 28 | 111 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | organic acid binding | 5.48e-04 | 254 | 111 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 6.32e-04 | 7 | 111 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.37e-04 | 193 | 111 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 7.57e-04 | 194 | 111 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.20e-04 | 197 | 111 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 8.39e-04 | 8 | 111 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 8.82e-04 | 34 | 111 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 9.61e-04 | 35 | 111 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.06e-03 | 207 | 111 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.09e-03 | 208 | 111 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.11e-03 | 140 | 111 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.13e-03 | 37 | 111 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.34e-03 | 10 | 111 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.34e-03 | 10 | 111 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.34e-03 | 10 | 111 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | amide binding | 1.42e-03 | 299 | 111 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.13e-03 | 46 | 111 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | glutamate binding | 2.67e-03 | 14 | 111 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.67e-03 | 14 | 111 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.81e-03 | 105 | 111 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.01e-03 | 107 | 111 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.24e-03 | 441 | 111 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG1 AXL ADGRG1 GRIK1 GRIN2B PTAFR OR5AR1 ADGRG6 FZD4 FZD7 OR14K1 TAS2R42 MS4A2 OR1E3 OR56A4 OR5D13 | 3.28e-03 | 1353 | 111 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | oxidoreductase activity | ACADM HSDL2 CYP11B1 CYP11B2 ACOX1 CYP24A1 CYP20A1 TMX2 MGST1 CYP2U1 CYP4F12 | 3.58e-03 | 766 | 111 | 11 | GO:0016491 |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.94e-03 | 17 | 111 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.94e-03 | 17 | 111 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ubiquitin-specific protease binding | 5.45e-03 | 20 | 111 | 2 | GO:1990381 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.69e-03 | 65 | 111 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.69e-03 | 65 | 111 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.94e-03 | 293 | 111 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | fatty acid binding | 6.71e-03 | 69 | 111 | 3 | GO:0005504 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1D ARL6IP5 SLC9C2 SLC38A1 SLC7A2 CD36 KCNJ12 CACNA1I KCNJ18 | 3.42e-06 | 230 | 108 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 7.67e-06 | 8 | 108 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.63e-05 | 10 | 108 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | TRPM6 GABRG1 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 2.09e-05 | 1017 | 108 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 2.39e-05 | 922 | 108 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.97e-05 | 12 | 108 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 3.10e-05 | 942 | 108 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 4.33e-05 | 74 | 108 | 5 | GO:0051932 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPM6 GABRG1 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 6.64e-05 | 1115 | 108 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 8.98e-05 | 45 | 108 | 4 | GO:0032228 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of blood volume | 1.08e-04 | 18 | 108 | 3 | GO:0001977 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | ACADM PDK1 ACOX1 PPARA PGM1 SLC38A1 CD36 UGT2B7 CYP2U1 SCPEP1 CYP4F12 UGT2B28 UGT2B11 | 1.16e-04 | 731 | 108 | 13 | GO:0032787 |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1D CYP11B1 CYP11B2 PPARA PTAFR SLC38A1 SLC7A2 CD36 KCNJ12 SCN4A SCPEP1 CYP4F12 ABCG2 | 1.19e-04 | 733 | 108 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 1.62e-04 | 4 | 108 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.73e-04 | 21 | 108 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | regulation of organic acid transport | 2.09e-04 | 103 | 108 | 5 | GO:0032890 | |
| GeneOntologyBiologicalProcess | metal ion transport | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 2.22e-04 | 1000 | 108 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPM6 GABRG1 CACNA1D CNNM2 SLC22A23 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 2.68e-04 | 1374 | 108 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of amino acid transport | 2.77e-04 | 60 | 108 | 4 | GO:0051955 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.32e-04 | 26 | 108 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.32e-04 | 26 | 108 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | TRPM6 CACNA1D CNNM2 GRIK1 GRIN2B HVCN1 SLC9C2 SLC38A1 CATSPER1 MS4A2 NALCN RAPGEF3 KCNJ12 SCN4A CACNA1I KCNJ18 | 3.36e-04 | 1157 | 108 | 16 | GO:0006812 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 5.50e-06 | 378 | 111 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 1.07e-04 | 523 | 111 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRG1 CACNA1D GRIK1 GRIN2B HVCN1 CATSPER1 NALCN KCNJ12 SCN4A CACNA1I KCNJ18 | 1.67e-04 | 550 | 111 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.08e-04 | 25 | 111 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 4.13e-04 | 6 | 111 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | sodium channel complex | 4.81e-04 | 29 | 111 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | motile cilium | 6.19e-04 | 355 | 111 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | brush border membrane | 1.00e-03 | 83 | 111 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | apical part of cell | TRPM6 CACNA1D PTEN HVCN1 SLC38A1 MGST1 RAPGEF3 CD36 CYP4F12 ABCG2 | 1.22e-03 | 592 | 111 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | inner dynein arm | 1.22e-03 | 10 | 111 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.25e-03 | 40 | 111 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.71e-03 | 238 | 111 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | terminal bouton | 1.72e-03 | 96 | 111 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.87e-03 | 46 | 111 | 3 | GO:0005891 | |
| HumanPheno | Dexamethasone-suppressible primary hyperaldosteronism | 5.15e-06 | 5 | 42 | 3 | HP:0011739 | |
| HumanPheno | Adrenocortical adenoma | 4.23e-05 | 9 | 42 | 3 | HP:0008256 | |
| HumanPheno | Primary hyperaldosteronism | 6.01e-05 | 10 | 42 | 3 | HP:0011736 | |
| HumanPheno | Neoplasm of the adrenal cortex | 7.08e-05 | 28 | 42 | 4 | HP:0100641 | |
| MousePheno | abnormal urine progesterone level | 3.74e-05 | 2 | 86 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 3.74e-05 | 2 | 86 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 3.74e-05 | 2 | 86 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 3.74e-05 | 2 | 86 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 3.74e-05 | 2 | 86 | 2 | MP:0011546 | |
| MousePheno | increased urine osmolality | 7.79e-05 | 14 | 86 | 3 | MP:0008055 | |
| MousePheno | endometrium hyperplasia | 7.79e-05 | 14 | 86 | 3 | MP:0009092 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 2.23e-04 | 4 | 86 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 2.23e-04 | 4 | 86 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 2.23e-04 | 4 | 86 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 2.23e-04 | 4 | 86 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 2.23e-04 | 4 | 86 | 2 | MP:0014459 | |
| Domain | Channel_four-helix_dom | 4.20e-08 | 57 | 110 | 7 | IPR027359 | |
| Domain | - | 4.20e-08 | 57 | 110 | 7 | 1.20.120.350 | |
| Domain | - | 1.15e-06 | 58 | 110 | 6 | 1.10.630.10 | |
| Domain | p450 | 1.15e-06 | 58 | 110 | 6 | PF00067 | |
| Domain | Cyt_P450 | 1.41e-06 | 60 | 110 | 6 | IPR001128 | |
| Domain | Ion_trans_dom | 4.97e-06 | 114 | 110 | 7 | IPR005821 | |
| Domain | Ion_trans | 4.97e-06 | 114 | 110 | 7 | PF00520 | |
| Domain | Cyt_P450_CS | 1.48e-05 | 53 | 110 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 2.12e-05 | 57 | 110 | 5 | PS00086 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 3.44e-05 | 2 | 110 | 2 | IPR003272 | |
| Domain | Cyt_P450_mitochondrial | 3.44e-05 | 2 | 110 | 2 | IPR002399 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.90e-05 | 14 | 110 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.90e-05 | 14 | 110 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.90e-05 | 14 | 110 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.90e-05 | 14 | 110 | 3 | PF08393 | |
| Domain | MT | 6.90e-05 | 14 | 110 | 3 | PF12777 | |
| Domain | AAA_8 | 6.90e-05 | 14 | 110 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 6.90e-05 | 14 | 110 | 3 | IPR011704 | |
| Domain | AAA_5 | 6.90e-05 | 14 | 110 | 3 | PF07728 | |
| Domain | DHC_fam | 8.59e-05 | 15 | 110 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.59e-05 | 15 | 110 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 8.59e-05 | 15 | 110 | 3 | PF03028 | |
| Domain | K_chnl_inward-rec_Kir_N | 1.03e-04 | 3 | 110 | 2 | IPR013673 | |
| Domain | IRK_N | 1.03e-04 | 3 | 110 | 2 | PF08466 | |
| Domain | Cyt_P450_E_grp-I | 1.41e-04 | 45 | 110 | 4 | IPR002401 | |
| Domain | UDPGT | 2.45e-04 | 21 | 110 | 3 | PF00201 | |
| Domain | UDPGT | 2.45e-04 | 21 | 110 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.45e-04 | 21 | 110 | 3 | IPR002213 | |
| Domain | GPCR_2_secretin-like | 4.31e-04 | 60 | 110 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 4.31e-04 | 60 | 110 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.59e-04 | 61 | 110 | 4 | PS50261 | |
| Domain | ARM-type_fold | 8.92e-04 | 339 | 110 | 8 | IPR016024 | |
| Domain | DHC_N1 | 9.40e-04 | 8 | 110 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.40e-04 | 8 | 110 | 2 | IPR013594 | |
| Domain | VDCCAlpha1 | 1.50e-03 | 10 | 110 | 2 | IPR002077 | |
| Domain | Frizzled | 1.83e-03 | 11 | 110 | 2 | IPR000539 | |
| Domain | Frizzled | 1.83e-03 | 11 | 110 | 2 | PF01534 | |
| Domain | Frizzled | 1.83e-03 | 11 | 110 | 2 | SM01330 | |
| Domain | - | 2.02e-03 | 222 | 110 | 6 | 1.25.10.10 | |
| Domain | AcylCoA_DH/ox_N | 2.57e-03 | 13 | 110 | 2 | IPR013786 | |
| Domain | - | 2.57e-03 | 13 | 110 | 2 | 1.10.540.10 | |
| Domain | - | 2.84e-03 | 48 | 110 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.37e-03 | 51 | 110 | 3 | IPR014710 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 3.43e-03 | 15 | 110 | 2 | IPR006091 | |
| Domain | Acyl-CoA_dh_M | 3.43e-03 | 15 | 110 | 2 | PF02770 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 3.43e-03 | 15 | 110 | 2 | IPR009100 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 3.91e-03 | 16 | 110 | 2 | IPR013518 | |
| Domain | IRK | 3.91e-03 | 16 | 110 | 2 | PF01007 | |
| Domain | - | 3.91e-03 | 16 | 110 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 3.91e-03 | 16 | 110 | 2 | IPR016449 | |
| Domain | AcylCo_DH/oxidase_C | 3.91e-03 | 16 | 110 | 2 | IPR009075 | |
| Domain | Frizzled/SFRP | 3.91e-03 | 16 | 110 | 2 | IPR015526 | |
| Domain | Iontro_rcpt | 4.95e-03 | 18 | 110 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 4.95e-03 | 18 | 110 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 4.95e-03 | 18 | 110 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 4.95e-03 | 18 | 110 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.95e-03 | 18 | 110 | 2 | SM00918 | |
| Domain | Lig_chan | 4.95e-03 | 18 | 110 | 2 | PF00060 | |
| Domain | PBPe | 4.95e-03 | 18 | 110 | 2 | SM00079 | |
| Domain | ARM-like | 5.29e-03 | 270 | 110 | 6 | IPR011989 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP11B1 CYP11B2 CYP24A1 CYP20A1 MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 1.79e-07 | 183 | 87 | 10 | M39588 |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.16e-06 | 62 | 87 | 6 | M39653 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 6.38e-06 | 43 | 87 | 5 | MM15873 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP11B1 CYP11B2 CYP24A1 MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 8.03e-06 | 219 | 87 | 9 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP11B1 CYP11B2 CYP24A1 MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 8.33e-06 | 220 | 87 | 9 | M10320 |
| Pathway | WP_GLUCURONIDATION | 1.55e-05 | 25 | 87 | 4 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 1.82e-05 | 26 | 87 | 4 | M39404 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.18e-05 | 55 | 87 | 5 | M14933 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.56e-05 | 64 | 87 | 5 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.30e-05 | 66 | 87 | 5 | MM14839 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 5.45e-05 | 34 | 87 | 4 | M27461 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 7.87e-05 | 14 | 87 | 3 | M46453 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.92e-04 | 52 | 87 | 4 | M14171 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 3.63e-04 | 153 | 87 | 6 | MM15844 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.68e-04 | 23 | 87 | 3 | MM16639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 3.72e-04 | 5 | 87 | 2 | M47522 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.18e-04 | 24 | 87 | 3 | MM14599 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.54e-04 | 104 | 87 | 5 | M738 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.73e-04 | 25 | 87 | 3 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.73e-04 | 25 | 87 | 3 | M605 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.74e-04 | 105 | 87 | 5 | MM14842 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.97e-04 | 27 | 87 | 3 | M47755 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.65e-04 | 28 | 87 | 3 | M19580 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 7.39e-04 | 29 | 87 | 3 | M39858 | |
| Pathway | WP_PPAR_SIGNALING | 7.71e-04 | 67 | 87 | 4 | M39553 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 8.62e-04 | 69 | 87 | 4 | M13088 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 9.10e-04 | 70 | 87 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.01e-03 | 72 | 87 | 4 | M9257 | |
| Pathway | WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS | 1.03e-03 | 8 | 87 | 2 | M45529 | |
| Pathway | REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM | 1.03e-03 | 8 | 87 | 2 | MM14766 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 1.07e-03 | 73 | 87 | 4 | MM15995 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.32e-03 | 9 | 87 | 2 | M26935 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M39819 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 1.32e-03 | 9 | 87 | 2 | MM14548 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.64e-03 | 10 | 87 | 2 | M27076 | |
| Pubmed | 1.02e-07 | 70 | 111 | 6 | 15128046 | ||
| Pubmed | Lipoprotein lipase activity is required for cardiac lipid droplet production. | 3.15e-07 | 5 | 111 | 3 | 24493834 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 7590346 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 11018072 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 26074487 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 32093886 | ||
| Pubmed | 2.31e-06 | 66 | 111 | 5 | 19898482 | ||
| Pubmed | 3.03e-06 | 193 | 111 | 7 | 19343046 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23150505 | ||
| Pubmed | USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN. | 1.01e-05 | 2 | 111 | 2 | 28852924 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 1.01e-05 | 2 | 111 | 2 | 21164264 | |
| Pubmed | HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression. | 1.01e-05 | 2 | 111 | 2 | 29958993 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 8645611 | ||
| Pubmed | CD36 and Platelet-Activating Factor Receptor Promote House Dust Mite Allergy Development. | 1.01e-05 | 2 | 111 | 2 | 28667161 | |
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 1.01e-05 | 2 | 111 | 2 | 12231255 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20634641 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 1303253 | ||
| Pubmed | Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma. | 1.01e-05 | 2 | 111 | 2 | 26722456 | |
| Pubmed | Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR. | 1.01e-05 | 2 | 111 | 2 | 24062612 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 1741400 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 32540969 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 14527087 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26047574 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26324851 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 7669222 | ||
| Pubmed | Rare novel CYP2U1 and ZFYVE26 variants identified in two Pakistani families with spastic paraplegia. | 1.01e-05 | 2 | 111 | 2 | 32006740 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22933298 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 1.01e-05 | 2 | 111 | 2 | 2256920 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15191668 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 1.01e-05 | 2 | 111 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 1.01e-05 | 2 | 111 | 2 | 16396990 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 14523052 | ||
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 1.01e-05 | 2 | 111 | 2 | 15705530 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 1.01e-05 | 2 | 111 | 2 | 18397978 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 1518866 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23303941 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 1.01e-05 | 2 | 111 | 2 | 2592361 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22266374 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23314847 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 1.01e-05 | 2 | 111 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 1.01e-05 | 2 | 111 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 1.01e-05 | 2 | 111 | 2 | 15731365 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 9918944 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10844002 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23603434 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17651452 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26465636 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 34743356 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 1.01e-05 | 2 | 111 | 2 | 20339375 | |
| Pubmed | Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha. | 1.01e-05 | 2 | 111 | 2 | 17084382 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20808686 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 1.01e-05 | 2 | 111 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 1.01e-05 | 2 | 111 | 2 | 21625068 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 16110193 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26066897 | ||
| Pubmed | Melanocyte stem cells express receptors for canonical Wnt-signaling pathway on their surface. | 1.01e-05 | 2 | 111 | 2 | 20450888 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17363697 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23143925 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18651133 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22083159 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 24347838 | ||
| Pubmed | Axl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion. | 1.01e-05 | 2 | 111 | 2 | 25332238 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10672038 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 1.01e-05 | 2 | 111 | 2 | 15699546 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18162527 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 38341019 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21679149 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 24837548 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 1.01e-05 | 2 | 111 | 2 | 19820005 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 1.01e-05 | 2 | 111 | 2 | 15062555 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17075030 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17075029 | ||
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 1.01e-05 | 2 | 111 | 2 | 15507509 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 33197885 | ||
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 1.01e-05 | 2 | 111 | 2 | 17296872 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 1.01e-05 | 2 | 111 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 1.01e-05 | 2 | 111 | 2 | 19029289 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10383430 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15522937 | ||
| Pubmed | 1.12e-05 | 14 | 111 | 3 | 9373155 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 2546938 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 16118390 | ||
| Pubmed | USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma. | 3.02e-05 | 3 | 111 | 2 | 30056112 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 17984374 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 2233742 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 33271253 | ||
| Pubmed | The prolactin regulatory element-binding regulates of the 11beta-hydroxylase gene. | 3.02e-05 | 3 | 111 | 2 | 18801336 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 28526781 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 11932209 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 20301512 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 21467193 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 34416231 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 10904001 | ||
| Interaction | DLG2 interactions | 5.56e-06 | 83 | 108 | 6 | int:DLG2 | |
| GeneFamily | Cytochrome P450 family 11 | 6.69e-05 | 3 | 86 | 2 | 1007 | |
| GeneFamily | Dyneins, axonemal | 6.73e-05 | 17 | 86 | 3 | 536 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 4.62e-04 | 7 | 86 | 2 | 917 | |
| GeneFamily | UDP glucuronosyltransferases | 4.66e-04 | 32 | 86 | 3 | 363 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.20e-03 | 11 | 86 | 2 | 286 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 2.57e-03 | 16 | 86 | 2 | 276 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.75e-03 | 26 | 86 | 2 | 253 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CACNA1D CNNM2 HSDL2 PLGRKT AXL TTC39C ADGRG1 PPARA FMNL2 PANK1 PPP4R4 TMX2 SLC7A2 MGST1 SCPEP1 | 7.59e-06 | 804 | 103 | 15 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CACNA1D HSDL2 AXL ADGRG1 PPARA KBTBD2 TRRAP FMNL2 PANK1 PPP4R4 SLC7A2 MGST1 CD36 TMEM131L | 2.81e-05 | 791 | 103 | 14 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CACNA1D CNNM2 HSDL2 PLGRKT ADGRG1 PPARA FMNL2 PANK1 PPP4R4 TMX2 SLC7A2 MGST1 CD36 TMEM131L | 3.32e-05 | 803 | 103 | 14 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 6.56e-05 | 87 | 103 | 5 | GSM605836_100 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-07 | 155 | 110 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-07 | 155 | 110 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-07 | 179 | 110 | 7 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 144 | 110 | 6 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-06 | 154 | 110 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-06 | 154 | 110 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 183 | 110 | 6 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 185 | 110 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.80e-06 | 190 | 110 | 6 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.78e-06 | 194 | 110 | 6 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 9.04e-06 | 195 | 110 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.31e-06 | 196 | 110 | 6 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.31e-06 | 196 | 110 | 6 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-05 | 159 | 110 | 5 | 1baf0eaf9684668146a63192e77eec6c3c7a37f8 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 5.93e-05 | 167 | 110 | 5 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-05 | 167 | 110 | 5 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 6.82e-05 | 172 | 110 | 5 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 173 | 110 | 5 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 7.40e-05 | 175 | 110 | 5 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 7.60e-05 | 176 | 110 | 5 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-05 | 176 | 110 | 5 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 7.60e-05 | 176 | 110 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 7.81e-05 | 177 | 110 | 5 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-05 | 178 | 110 | 5 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-05 | 178 | 110 | 5 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 179 | 110 | 5 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 179 | 110 | 5 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-05 | 180 | 110 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.45e-05 | 180 | 110 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | CF-Myeloid-Alveolar_Macrophage|CF / Disease state, Lineage and Cell class | 8.45e-05 | 180 | 110 | 5 | 6a7c3a3f3a16ca9f109047adaf36f6a2746d6ab9 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.67e-05 | 181 | 110 | 5 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 183 | 110 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-05 | 183 | 110 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.13e-05 | 183 | 110 | 5 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 183 | 110 | 5 | 1614704fe0d8cd4c54c49f93f0cefb790ca897c7 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.37e-05 | 184 | 110 | 5 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.61e-05 | 185 | 110 | 5 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.86e-05 | 186 | 110 | 5 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 186 | 110 | 5 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | Club-club-14|World / Class top | 1.01e-04 | 187 | 110 | 5 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.01e-04 | 187 | 110 | 5 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.01e-04 | 187 | 110 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | a7158b5c94e6b356877f016e52f2c24a3f5d24d2 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 188 | 110 | 5 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 188 | 110 | 5 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 188 | 110 | 5 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 188 | 110 | 5 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 110 | 5 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 189 | 110 | 5 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 189 | 110 | 5 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 189 | 110 | 5 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 189 | 110 | 5 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 110 | 5 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 110 | 5 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 110 | 5 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 110 | 5 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 110 | 5 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.09e-04 | 190 | 110 | 5 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 110 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.09e-04 | 190 | 110 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 191 | 110 | 5 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | 3a99c521c599a289ee2309d97be5ceb99f8aa220 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | f9777e0fdd86c2a514f05a42502888329a94b396 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | 562e15876088af9189744c9b2de5c4863d7f15fd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 192 | 110 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| ToppCell | (4)_Endothelial_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.17e-04 | 193 | 110 | 5 | ae6ba13d4d9f2a700887cdda2790c32007b29ac8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 193 | 110 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 193 | 110 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.20e-04 | 194 | 110 | 5 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 194 | 110 | 5 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 194 | 110 | 5 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 195 | 110 | 5 | fca958f73de450ef813444d3dc590353f1c55326 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.26e-04 | 196 | 110 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 197 | 110 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 198 | 110 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.32e-04 | 198 | 110 | 5 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| Drug | hexobarbital | GABRG1 CYP11B1 CYP11B2 CYP24A1 CYP20A1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 4.97e-10 | 127 | 108 | 10 | CID000003608 |
| Drug | phenobarbital | GABRG1 CYP11B1 CYP11B2 CYP24A1 CYP20A1 GRIK1 GRIN2B PPARA MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 1.73e-09 | 360 | 108 | 14 | CID000004763 |
| Drug | clofibrate | CYP11B1 CYP11B2 ACOX1 CYP24A1 CYP20A1 PPARA ADCY2 MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 2.89e-09 | 311 | 108 | 13 | CID000002796 |
| Drug | halothane | GABRG1 CACNA1D CYP11B1 CYP11B2 CYP24A1 CYP20A1 GRIK1 ADCY2 CATSPER1 MGST1 CYP2U1 CACNA1I CYP4F12 | 3.25e-09 | 314 | 108 | 13 | CID000003562 |
| Drug | AC1Q7AUJ | CYP11B1 CYP11B2 CYP24A1 CYP20A1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 4.68e-09 | 117 | 108 | 9 | CID000003303 |
| Drug | dioxin | CYP11B1 CYP11B2 ACOX1 CYP24A1 CYP20A1 UGT2B7 CYP2U1 CYP4F12 ABCG2 TNFAIP1 UGT2B28 UGT2B11 | 9.77e-08 | 347 | 108 | 12 | CID000015625 |
| Drug | felodipine | CACNA1D CYP11B1 CYP11B2 CYP24A1 CYP20A1 CATSPER1 CYP2U1 CACNA1I CYP4F12 | 1.15e-07 | 169 | 108 | 9 | CID000003333 |
| Drug | aminopyrine | CYP11B1 CYP11B2 CYP24A1 CYP20A1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 1.27e-07 | 171 | 108 | 9 | CID000006009 |
| Drug | diosmetin | 1.62e-07 | 85 | 108 | 7 | CID005281612 | |
| Drug | chloral hydrate | 1.87e-07 | 129 | 108 | 8 | CID000002707 | |
| Drug | 3 -hydroxypregn-5-en-20-one | GABRG1 CYP11B1 CYP11B2 CYP24A1 CYP20A1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 2.04e-07 | 238 | 108 | 10 | CID000001027 |
| Drug | tienilic acid | 3.01e-07 | 93 | 108 | 7 | CID000038409 | |
| Drug | alprazolam | GABRG1 CYP11B1 CYP11B2 CYP24A1 CYP20A1 GRIK1 PTAFR CYP2U1 CYP4F12 | 3.56e-07 | 193 | 108 | 9 | CID000002118 |
| Drug | caffeine | CACNA1D CYP11B1 CYP11B2 CYP24A1 CYP20A1 GRIK1 GRIN2B ADCY2 CATSPER1 CYP2U1 SCPEP1 CACNA1I CYP4F12 TNFAIP1 | 4.41e-07 | 562 | 108 | 14 | CID000002519 |
| Drug | tolbutamide | CYP11B1 CYP11B2 CYP24A1 CYP20A1 ADCY2 PGM1 KCNJ12 CYP2U1 CYP4F12 | 4.42e-07 | 198 | 108 | 9 | CID000005505 |
| Drug | Sparteinum | 5.29e-07 | 101 | 108 | 7 | CID000003966 | |
| Drug | nifedipine | CACNA1D CYP11B1 CYP11B2 CYP24A1 CYP20A1 GRIK1 GRIN2B CATSPER1 CYP2U1 CACNA1I CYP4F12 TNFAIP1 | 6.62e-07 | 415 | 108 | 12 | CID000004485 |
| Drug | propoxyphene | 7.81e-07 | 67 | 108 | 6 | CID000010100 | |
| Drug | potassium | GABRG1 CACNA1D PDK1 CYP11B1 CYP11B2 GRIK1 GRIN2B ADCY2 SLC38A1 MRPS7 SLC7A2 CATSPER1 RAPGEF3 KCNJ12 SCN4A CACNA1I ABCG2 TNFAIP1 | 1.18e-06 | 1008 | 108 | 18 | CID000000813 |
| Drug | carteolol | 1.20e-06 | 72 | 108 | 6 | CID000002583 | |
| Drug | aminotriazole | 1.34e-06 | 167 | 108 | 8 | CID000001639 | |
| Drug | trimipramine | 2.24e-06 | 80 | 108 | 6 | CID000005584 | |
| Drug | tectoridin | 3.58e-06 | 7 | 108 | 3 | ctd:C120040 | |
| Drug | NSC9700 | ABCA4 CYP11B1 CYP11B2 CYP24A1 CYP20A1 ADCY2 CD36 UGT2B7 CYP2U1 CYP4F12 TNFAIP1 UGT2B28 UGT2B11 | 3.61e-06 | 578 | 108 | 13 | CID000005408 |
| Drug | baclofen | 3.64e-06 | 191 | 108 | 8 | CID000002284 | |
| Drug | mephenytoin | 3.91e-06 | 88 | 108 | 6 | CID000004060 | |
| Drug | oltipraz | 4.12e-06 | 137 | 108 | 7 | CID000047318 | |
| Drug | AC1NQGK1 | 4.76e-06 | 52 | 108 | 5 | CID005195977 | |
| Drug | epoxiconazole | CACNA1D CYP11B1 CYP11B2 TTC39C GRIK1 GRIN2B PPARA TMX2 CD36 CACNA1I | 5.26e-06 | 341 | 108 | 10 | ctd:C109476 |
| Drug | lansoprazole | 5.40e-06 | 93 | 108 | 6 | CID000003883 | |
| Drug | nimodipine | 5.99e-06 | 145 | 108 | 7 | CID000004497 | |
| Drug | AC1L1HMM | CYP11B1 CYP11B2 CYP24A1 CYP20A1 PPARA ADCY2 FZD4 CYP2U1 CACNA1I CYP4F12 ABCG2 TNFAIP1 | 6.27e-06 | 516 | 108 | 12 | CID000004196 |
| Drug | dehydroepiandrosterone sulfate | GABRG1 ABCA4 CYP11B1 CYP11B2 ACOX1 GRIN2B PPARA ABCG2 TNFAIP1 | 7.01e-06 | 277 | 108 | 9 | CID000005244 |
| Drug | diclofenac | 7.07e-06 | 209 | 108 | 8 | CID000003032 | |
| Drug | 2-chloropropionate | 7.72e-06 | 27 | 108 | 4 | CID000011734 | |
| Drug | AC1L1KIN | 8.22e-06 | 100 | 108 | 6 | CID000005516 | |
| Drug | chiglitazar | 8.54e-06 | 9 | 108 | 3 | ctd:C515629 | |
| Drug | GW 501516 | 1.24e-05 | 63 | 108 | 5 | ctd:C425931 | |
| Drug | gabapentin | 1.63e-05 | 169 | 108 | 7 | CID000003446 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | TRPM6 CACNA1D ABCA4 GRIK1 GRIN2B PPARA ADCY2 MRPS7 CATSPER1 RAPGEF3 CACNA1I TNFAIP1 | 1.91e-05 | 577 | 108 | 12 | CID000000295 |
| Drug | lamotrigine | 1.93e-05 | 116 | 108 | 6 | CID000003878 | |
| Drug | riluzole | 1.97e-05 | 174 | 108 | 7 | CID000005070 | |
| Drug | 8-MOP | 2.12e-05 | 118 | 108 | 6 | CID000004114 | |
| Drug | cyadox | 2.23e-05 | 2 | 108 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 2.23e-05 | 2 | 108 | 2 | ctd:C042509 | |
| Drug | 2-hydroxyestriol | 2.23e-05 | 2 | 108 | 2 | ctd:C008012 | |
| Drug | LS-63783 | CYP11B1 CYP11B2 CYP24A1 CYP20A1 PPARA PTAFR ADCY2 MS4A2 MGST1 CD36 UGT2B7 CYP2U1 CYP4F12 TNFAIP1 | 2.70e-05 | 804 | 108 | 14 | CID000000231 |
| Drug | perfluorononanoic acid | 2.90e-05 | 75 | 108 | 5 | ctd:C584865 | |
| Drug | lignoceroyl-CoA | 3.47e-05 | 39 | 108 | 4 | CID003082227 | |
| Drug | harmol | 3.84e-05 | 40 | 108 | 4 | CID000068094 | |
| Drug | acipimox | 4.24e-05 | 41 | 108 | 4 | ctd:C027696 | |
| Drug | testosterone glucuronide | 4.24e-05 | 41 | 108 | 4 | CID000108192 | |
| Drug | Biliton | 4.24e-05 | 41 | 108 | 4 | CID000002974 | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; PC3; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 5090_DN | |
| Drug | 2-butyl-6-methoxyphenol | 4.35e-05 | 197 | 108 | 7 | CID011954184 | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 3004_UP | |
| Drug | aminoglutethimide | 4.92e-05 | 137 | 108 | 6 | CID000002145 | |
| Drug | pentoxyresorufin | 5.93e-05 | 87 | 108 | 5 | CID000107683 | |
| Drug | Androstenedione | 6.14e-05 | 45 | 108 | 4 | ctd:D000735 | |
| Drug | propylphosphonic acid | 6.67e-05 | 3 | 108 | 2 | CID006328099 | |
| Drug | AC1L1H8N | 6.67e-05 | 3 | 108 | 2 | CID000004023 | |
| Drug | Toximul MP8 | 6.67e-05 | 3 | 108 | 2 | ctd:C019116 | |
| Drug | 18-hydroxycortisol | 6.67e-05 | 3 | 108 | 2 | ctd:C033689 | |
| Drug | efonidipine | 6.72e-05 | 17 | 108 | 3 | CID000119170 | |
| Drug | 2 E1 | 6.75e-05 | 145 | 108 | 6 | CID006102788 | |
| Drug | C1 11-32 | 8.04e-05 | 18 | 108 | 3 | CID000443077 | |
| Drug | C11131 | 8.04e-05 | 18 | 108 | 3 | CID000443076 | |
| Drug | ethylnylestradiol | AXL CYP11B1 CYP11B2 ACOX1 CYP24A1 CYP20A1 GRIN2B PPARA PTEN CD36 UGT2B7 CYP2U1 CACNA1I CYP4F12 ABCG2 TNFAIP1 UGT2B28 | 8.15e-05 | 1251 | 108 | 17 | CID000003285 |
| Drug | diisononyl phthalate | 9.32e-05 | 50 | 108 | 4 | ctd:C012125 | |
| Drug | T4-G | 9.52e-05 | 19 | 108 | 3 | CID000152424 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 9.76e-05 | 302 | 108 | 8 | ctd:D003633 | |
| Drug | azelnidipine | 1.01e-04 | 51 | 108 | 4 | CID000065948 | |
| Drug | propafenone | 1.05e-04 | 98 | 108 | 5 | CID000004932 | |
| Drug | nitrendipine | 1.05e-04 | 98 | 108 | 5 | CID000004507 | |
| Drug | Oleic Acid | 1.05e-04 | 98 | 108 | 5 | ctd:D019301 | |
| Drug | rifampicin | 1.07e-04 | 306 | 108 | 8 | CID005381226 | |
| Drug | tetrahydroaldosterone | 1.12e-04 | 20 | 108 | 3 | CID000122135 | |
| Drug | 11 alpha-hydroxyprogesterone | 1.12e-04 | 20 | 108 | 3 | CID000092730 | |
| Drug | verapamil | CACNA1D ABCA4 CYP24A1 ADCY2 MRPS7 CATSPER1 KCNJ12 SCN4A CACNA1I ABCG2 | 1.15e-04 | 490 | 108 | 10 | CID000002520 |
| Drug | oxazepam | 1.17e-04 | 53 | 108 | 4 | CID000004616 | |
| Drug | estriol-16-glucuronide | 1.30e-04 | 21 | 108 | 3 | CID000122281 | |
| Drug | methanethiosulfonate | 1.32e-04 | 103 | 108 | 5 | CID004188587 | |
| Drug | C05489 | 1.33e-04 | 4 | 108 | 2 | CID000440708 | |
| Drug | paraoxon | 1.33e-04 | 164 | 108 | 6 | CID000009395 | |
| Drug | sodium cholate | CYP11B2 ACOX1 CYP24A1 PPARA MRPS7 UGT2B7 ABCG2 UGT2B28 UGT2B11 | 1.43e-04 | 408 | 108 | 9 | CID000000303 |
| Drug | phenylpropionic acid | 1.47e-04 | 167 | 108 | 6 | CID000000107 | |
| Drug | dodecanedioic acid | 1.50e-04 | 22 | 108 | 3 | CID000012736 | |
| Drug | chrysin | 1.52e-04 | 106 | 108 | 5 | CID005281607 | |
| Drug | adipic acid | 1.67e-04 | 58 | 108 | 4 | CID000000196 | |
| Drug | ethanol | GABRG1 CACNA1D ACOX1 GRIN2B PPARA PTEN ADCY2 PPP2R5E MGST1 SCN4A CACNA1I TNFAIP1 SMG6 | 1.68e-04 | 837 | 108 | 13 | CID000000702 |
| Drug | NSC303808 | 1.72e-04 | 23 | 108 | 3 | CID000327720 | |
| Drug | estradiol-3-glucuronide | 1.72e-04 | 23 | 108 | 3 | CID000066651 | |
| Drug | acetaminophen glucuronide | 1.78e-04 | 59 | 108 | 4 | CID000083944 | |
| Drug | SN-38G | 1.78e-04 | 59 | 108 | 4 | CID000443154 | |
| Drug | NADP(H | CYP11B1 CYP11B2 CYP24A1 BTAF1 MGST1 UGT2B7 CYP2U1 CYP4F12 UGT2B28 UGT2B11 | 2.07e-04 | 527 | 108 | 10 | CID000000930 |
| Drug | carbamazepine | 2.14e-04 | 179 | 108 | 6 | CID000002554 | |
| Drug | metyrapone | 2.14e-04 | 179 | 108 | 6 | CID000004174 | |
| Drug | 17alpha, 21-dihydroxypregnenolone | 2.21e-04 | 5 | 108 | 2 | CID000192735 | |
| Drug | hugan qingzhi | 2.21e-04 | 5 | 108 | 2 | ctd:C000594496 | |
| Drug | Hymecromone | 2.21e-04 | 25 | 108 | 3 | ctd:D006923 | |
| Disease | Conn Syndrome | 9.20e-07 | 6 | 107 | 3 | C1384514 | |
| Disease | Hyperaldosteronism | 9.20e-07 | 6 | 107 | 3 | C0020428 | |
| Disease | Glucocorticoid-remediable aldosteronism | 1.30e-05 | 2 | 107 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 1.30e-05 | 2 | 107 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2 | 1.30e-05 | 2 | 107 | 2 | C2750473 | |
| Disease | Hypokalemic periodic paralysis type 1 | 3.90e-05 | 3 | 107 | 2 | C3714580 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 7.78e-05 | 4 | 107 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 1.29e-04 | 5 | 107 | 2 | DOID:446 (is_implicated_in) | |
| Disease | protocadherin alpha-7 measurement | 2.70e-04 | 7 | 107 | 2 | EFO_0801973 | |
| Disease | vitamin D deficiency | 3.29e-04 | 37 | 107 | 3 | EFO_0003762 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 4.61e-04 | 9 | 107 | 2 | EFO_0600040 | |
| Disease | protein FAM163B measurement | 4.61e-04 | 9 | 107 | 2 | EFO_0802936 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.72e-04 | 99 | 107 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | androstenedione measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0007972 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0021862 | |
| Disease | Beta blocking agent use measurement | 8.03e-04 | 114 | 107 | 4 | EFO_0009929 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0004612, GO_0036270 | |
| Disease | paraxanthine measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0021178 | |
| Disease | esophageal cancer (is_marker_for) | 8.40e-04 | 12 | 107 | 2 | DOID:5041 (is_marker_for) | |
| Disease | Congenital myopathy (disorder) | 8.40e-04 | 12 | 107 | 2 | C0270960 | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 9.90e-04 | 13 | 107 | 2 | DOID:10584 (biomarker_via_orthology) | |
| Disease | X-19141 measurement | 9.90e-04 | 13 | 107 | 2 | EFO_0800799 | |
| Disease | forehead morphology measurement | 1.33e-03 | 15 | 107 | 2 | EFO_0007844 | |
| Disease | Insulin Resistance | 1.37e-03 | 60 | 107 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 1.37e-03 | 60 | 107 | 3 | C0920563 | |
| Disease | disease progression measurement | 1.43e-03 | 61 | 107 | 3 | EFO_0008336 | |
| Disease | hypertension (biomarker_via_orthology) | 1.45e-03 | 227 | 107 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 1.51e-03 | 16 | 107 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | fatty liver disease (is_marker_for) | 1.71e-03 | 17 | 107 | 2 | DOID:9452 (is_marker_for) | |
| Disease | cyclic adenosine monophosphate measurement | 1.71e-03 | 17 | 107 | 2 | EFO_0010473 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 1.71e-03 | 17 | 107 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 36:4 measurement | 1.92e-03 | 18 | 107 | 2 | EFO_0010382 | |
| Disease | Tourette syndrome, schizophrenia | 1.92e-03 | 18 | 107 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.96e-03 | 68 | 107 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | urinary metabolite measurement | 2.03e-03 | 245 | 107 | 5 | EFO_0005116 | |
| Disease | diabetes mellitus (biomarker_via_orthology) | 2.14e-03 | 19 | 107 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | axial length measurement | 2.79e-03 | 77 | 107 | 3 | EFO_0005318 | |
| Disease | X-24947 measurement | 2.87e-03 | 22 | 107 | 2 | EFO_0800910 | |
| Disease | Asthma | 3.11e-03 | 80 | 107 | 3 | C0004096 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.54e-03 | 171 | 107 | 4 | DOID:9352 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKAFMEMNSTMFDEL | 411 | Q16537 | |
| STRMLQLMTINMFAV | 936 | Q86US8 | |
| KCFMASFSTEIVVMM | 171 | Q01362 | |
| FFIMAMAVLDFLLMQ | 516 | Q8NEC5 | |
| SIMSMSIFLLTIFIM | 706 | P78363 | |
| TMLKAMFSGRMEVLT | 51 | Q13829 | |
| LMSMHNVKIFMFQLL | 236 | Q07002 | |
| VMFFLNIAMFIVVMV | 1031 | Q86SQ4 | |
| FTIFKAMMVQKNIEM | 106 | Q96G28 | |
| AAEILKQILFMGMMT | 236 | P39086 | |
| VATLLMTICFVFMMI | 536 | Q9UNQ0 | |
| MSGVFMEMVKASATV | 46 | Q9Y6B7 | |
| HQAISFMLAEMAMKV | 316 | P11310 | |
| MQEANLTSMVLFMKR | 421 | Q7L7V1 | |
| MAFLFDLKALVDMMS | 401 | P52569 | |
| LVMCVYTKSMFITLM | 516 | Q96F81 | |
| TITFNINKVMMFCGM | 811 | Q96MT7 | |
| YNMMTKTQMFIRFIE | 616 | Q7Z401 | |
| MMKDLEALMFDRSFV | 441 | P36871 | |
| LASKSMEQFMKLVGM | 346 | O95294 | |
| FYVADMIISAMEKMK | 211 | Q9H714 | |
| IFSKEMFKNTMALMD | 196 | Q9Y6F1 | |
| MVFELFKNAMRATME | 276 | Q15118 | |
| FLQMFIMNSFLTMES | 101 | Q8NGH8 | |
| IMNSFLTMESCTFMV | 106 | Q8NGH8 | |
| QAVNSKMFEMGMKIT | 471 | Q9NRJ5 | |
| IIDSFMIGAIMAKMA | 171 | Q14500 | |
| TTMFYSKILGMEVMT | 51 | A6NK44 | |
| FASYATIILSKMMLM | 16 | P10620 | |
| YMSITILVFFMMEII | 141 | Q96D96 | |
| MGFIFSKSMNESMKN | 1 | Q9HBL7 | |
| MTNQTQMMEFLLVRF | 1 | Q8NGZ2 | |
| LGMTKEEMMIFIEAS | 261 | Q8IY47 | |
| DVVMSMTTDDFVKMF | 366 | Q6YN16 | |
| VMFTNCMQKFTQSMK | 756 | Q9BSJ2 | |
| ITLMAAVMLVIFYKM | 536 | Q9HCJ2 | |
| SNMGKTMLEFQELMT | 151 | Q8N485 | |
| MGEQLAKMELFLMFV | 491 | Q7Z449 | |
| AKMELFLMFVSLMQS | 496 | Q7Z449 | |
| MVNSLYMMKTTLALF | 501 | Q9Y2V7 | |
| DSNMAVEMLKIFMSL | 471 | Q9ULV1 | |
| DFTVFMIKYLMTMIV | 526 | O75084 | |
| IIKLTEAMTMMFEVQ | 1976 | Q9P2D7 | |
| VMMLQTARFLMKSYD | 426 | Q15067 | |
| TTAIILMMAVFNMFF | 686 | Q08462 | |
| MAFLMKSMISNQVKN | 1 | Q7Z7G2 | |
| GVMSKIATMETMNIF | 1131 | O14981 | |
| VNFIMAIKTMMSTFG | 236 | Q07973 | |
| FNSTMKVLMLNSNMV | 126 | Q8N1C3 | |
| VLTFNLLEERMMTKM | 291 | Q96JJ3 | |
| MILLSVGVVMFVAFM | 446 | P16671 | |
| FAMEMVLKMVALGIF | 126 | Q9P0X4 | |
| QAFAMAEMKVVLALM | 471 | Q9HCS2 | |
| ALEVMFKSTVQLMFM | 226 | P15538 | |
| FSKFTMEMVRQYMKE | 1676 | Q5VT06 | |
| VFLFNMAMLATMVVQ | 581 | Q9Y653 | |
| ERLMQKMTIMAFIGN | 776 | Q96PY5 | |
| ALEVMFKSTVQLMFM | 226 | P19099 | |
| ARDEFNLQKMMVMVT | 526 | Q8N766 | |
| FAMKSVTQMVMGSTF | 171 | Q6UW02 | |
| TMMFSATFPKEIQML | 376 | O15523 | |
| MVVTFLMSALESMCK | 21 | P78347 | |
| MTETFTLENMFAMEL | 1361 | Q8IVF4 | |
| KMFNDAMDILNMVFT | 1231 | Q01668 | |
| MDMVFFADAMVHLVK | 2926 | Q8TE73 | |
| VALLFHKMMFETIPM | 191 | P60484 | |
| MMKKNQTMISEFLLL | 1 | Q8WZA6 | |
| ILTSYMLIFTTIMKM | 216 | Q8NGL4 | |
| AIFAMLSSVMNKDGM | 316 | Q07869 | |
| INMVSMKLLAYAMDF | 551 | Q8TE04 | |
| RAMKMVMSFLFLFIV | 231 | Q7RTR8 | |
| FIKVLLYMAFMTIMI | 221 | Q86TM6 | |
| LYMAFMTIMIKVHTF | 226 | Q86TM6 | |
| IIDSFMIGAIMAKMA | 171 | B7U540 | |
| FEDPVISKFTNMMMI | 86 | Q9Y2R9 | |
| FLQRMFTIMMTNNVL | 526 | Q6NUP7 | |
| FIMITILTNCVFMTM | 136 | P35499 | |
| LRLQMSIMVTMENFS | 256 | A2VDJ0 | |
| EIKIFMVNLTMADML | 51 | P25105 | |
| AMVASDMMVLLKTFF | 136 | Q9HB40 | |
| MITMVASFVAMAGQF | 316 | A1A5C7 | |
| TMKQFMDIFSLPEMT | 211 | Q86UY8 | |
| FVMVVMLASYFLISM | 101 | O75915 | |
| AMKVFDVVNFDMINM | 156 | Q96BP3 | |
| KMTQIMFETFNTPAM | 781 | P0CG39 | |
| QKAFFAKMVVDAVMM | 171 | Q99832 | |
| FEVKMMLMNLISRLV | 311 | Q9NVU7 | |
| MDKENSSMVTEFIFM | 1 | Q8NGP9 | |
| VGANTIFLTKFFMMM | 371 | Q9H8M5 | |
| VEILMFLSAIVMMKN | 66 | Q9Y320 | |
| TLVENLINFEKMRMM | 831 | O95398 | |
| TKEQILDMLVMEQFM | 76 | P0CG00 | |
| AKMTANMFYIVIIMA | 971 | Q9BX84 | |
| LKRFDMAVMFMSETE | 621 | Q9H6T3 | |
| IKAMKMGFEFNIMVV | 41 | Q8IYM1 | |
| TQMLVKFMADIASGM | 646 | P30530 | |
| LSDQMTFMERVKNMI | 201 | O75310 | |
| MAAELVEAKNMVMSF | 1 | Q8N2W9 | |
| IDFEEFLVMMVRQMK | 71 | P02585 | |
| ALQETNMKFSMMLRE | 1481 | Q15643 | |
| MIDSFVRLMNEFTNM | 461 | Q14694 | |
| DMIIDNMTMKFVIIV | 1036 | Q5TAH2 | |
| MSDFIMKVDALMSSV | 921 | Q9NYU1 | |
| LSDQMTFMERVKNMI | 201 | Q9BY64 | |
| LTDQMTFMERVKNMI | 201 | P16662 | |
| FLNAMMTFEEEKMQL | 71 | Q8N584 | |
| FDKDVVMLQTGVSMM | 691 | Q8IWV8 | |
| TDIMKQLLFSAKMMF | 1976 | Q68DK2 | |
| AVMSMEMRKNFIQAI | 2336 | Q9Y4A5 | |
| KMQMVSNISFFAMFV | 306 | Q9H2H9 | |
| STAMRQMVFMQKQVL | 191 | Q8WXB4 | |
| MQCFSFIKTMMILFN | 1 | O60635 | |
| TLLMFLYTAEMIAKM | 76 | Q8IZF0 | |
| MMFVMLLIVSAVAVF | 561 | Q13224 |